Cambridge Investment Research Advisors, Inc. Teva Pharmaceutical Industries LTD Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 88,393 shares of TEVA stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88,393
Previous 84,263
4.9%
Holding current value
$1.81 Million
Previous $1.3 Million
14.36%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding TEVA
# of Institutions
659Shares Held
667MCall Options Held
30.1MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$880 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$788 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$785 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$774 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$773 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $22.7B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...